When Postmastectomy Radiotherapy (PMRT) Is Not Really PMRT: A Critical Evaluation of SUPREMO Trial
Authors: George E. Naoum MD, MMSCI & Alphonse G. Taghian MD, PHD
Date of Acceptance: February 26, 2026.
Expert Commentary: The SUPREMO trial reported that chest-wall-irradiation alone did not improve disease-free or overall survival. The lessons learned depend on which patients were included in the trial.
Complex General Surgical Oncology (CGSO) Entrustable Professional Activities: An Opportunity for Mixed Methods Longitudinal Feedback
Authors: Kristen Jogerst MD, MPH & Heather A. Lillemoe MD, FACS
Date of Acceptance: March 26, 2026.
Expert Commentary: Complex General Surgical Oncology fellowship training has rolled out EPAs (Entrustable Professional Activities). Is your feedback having the impact you expect?
Assessment of Survival Benefit From Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-Analysis
Authors: Edmund K. Bartlett, MD, Katherine S. Panageas, DrPH, MS, & Daniel G. Coit, MD
Date of Acceptance: April 26, 2026.
Expert Commentary: Back to the future — A large meta-analysis to address the recurring question, “Does earlier surgical removal of melanoma nodal metastasis improve survival?”
Networking Is Essential for the Proper Management of Rare Cancers: From Recognition to Implementation
Authors: Laurent Villeneuve, PhD, Vahan Kepenekian, MD, PhD, & Olivier Glehen, MD, PhD
Date of Acceptance: June 26, 2026.
Expert Commentary: Creation of networks is essential for handling rare cancers. The core principle of the network model is simple: expertise should travel, not the patient.